Liver transplant breakthrough: could stem cells end a lifetime of pills?
NCT ID NCT07269041
First seen Jan 04, 2026 · Last updated May 19, 2026 · Updated 23 times
Summary
This study tests whether a one-time infusion of donor stem cells, combined with low-dose radiation and immune therapy, can retrain the immune system to accept a liver transplant without lifelong anti-rejection drugs. The goal is to safely wean 12 adult liver transplant recipients off their immunosuppressant medications within a year. If successful, this could dramatically reduce side effects and improve quality of life for transplant patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for END STAGE LIVER DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
UCLA Health 200 Medical Plaza
RECRUITINGLos Angeles, California, 90095, United States
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.